These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8904521)

  • 21. Recombinant human erythropoietin in the treatment of cancer-related anaemia.
    Kasper C; Terhaar A; Fosså A; Welt A; Seeber S; Nowrousian MR
    Eur J Haematol; 1997 Apr; 58(4):251-6. PubMed ID: 9186536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
    Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
    Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anemia in puerperium; parenteral iron substitution renders erythropoietin therapy dispensable].
    Lebrecht A; Häberlin F; Eberhard J
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):167-70. PubMed ID: 7665066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin.
    Major A; Mathez-Loic F; Rohling R; Gautschi K; Brugnara C
    Br J Haematol; 1997 Aug; 98(2):292-4. PubMed ID: 9266922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 1998 Nov; 13(11):2867-72. PubMed ID: 9829492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron-deficient erythropoiesis in neonatal rats.
    Dubuque SH; Dvorak B; Woodward SS; McCuskey RS; Kling PJ
    Biol Neonate; 2002 Jan; 81(1):51-7. PubMed ID: 11803177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin.
    De Marchi S; Cecchin E
    Clin Sci (Lond); 1991 Jul; 81(1):113-21. PubMed ID: 1649718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients.
    do Sameiro-Faria M; Ribeiro S; Rocha-Pereira P; Fernandes J; Reis F; Bronze-da-Rocha E; Miranda V; Quintanilha A; Costa E; Belo L; Santos-Silva A
    Ren Fail; 2013; 35(10):1392-8. PubMed ID: 23991655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
    Schaefer RM; Schaefer L
    J Perinat Med; 1995; 23(1-2):83-8. PubMed ID: 7658326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome.
    Matzkies FK; Cullen P; Schaefer L; Hartmann M; Hohage H; Schaefer RM
    South Med J; 1999 Dec; 92(12):1157-61. PubMed ID: 10624905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial.
    Rössler J; Hegemann I; Schoenrath F; Seifert B; Kaserer A; Spahn GH; Falk V; Spahn DR
    Anaesthesia; 2020 Aug; 75(8):1039-1049. PubMed ID: 32342498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
    Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
    Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
    Bader D; Blondheim O; Jonas R; Admoni O; Abend-Winger M; Reich D; Lanir A; Tamir A; Eldar I; Attias D
    Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
    Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
    Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.